Nyxoah
NYXH | NASDAQ
$0.89
-$0.01 (-1.06%)
At close: Nov 16, 2026, 4:00 PM ET
$0.89
$0.00 (+0.42%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Nyxoah Company Profile
Company profile explainedCompany Profile
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Key Executives
| Name | Position |
|---|---|
| Liam J. Kelly | Chief Executive Officer |
| Olivier Taelman | Chief Executive Officer |
| John Landry | Chief Financial Officer |
| An Moonen | General Counsel |
| Ashlea Mittelstaedt | Chief Strategy Officer |
| Bruno Onkelinx | Chief Technical Officer |
| Geeta Kaveti | Chief Compliance Officer |
| Jeyakumar Subbaroyan | Chief Science Officer |
| Loic Moreau | President of International & Interim CFO |
| Maurits S. Boon | Chief Medical Officer |
| Pearson Dennis | Investor Relations Associate |
| Remi Renard | Head of Investor Relations & Corporate Communication |
| Robert Taub | Co-Founder & Chairman |
| Scott Holstine | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 20, 2026 | 6-K | Filing |
| Sep 29, 2026 | 6-K | Filing |
| Sep 22, 2026 | 6-K | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 05, 2026 | 6-K | Filing |
| Jul 09, 2026 | 6-K | Filing |
| Jul 01, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 23, 2026 | 6-K | Filing |
| Jun 22, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jun 11, 2026 | 6-K | Filing |
Nyxoah
| Country | Belgium |
| IPO Date | Apr 28, 2021 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 154 |
| CEO | Liam J. Kelly |
Contact Details
Rue Edouard Belin 12 Mont-Saint-Guibert,
Washington 1435 Belgium
Stock Details
| Ticker Symbol | NYXH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001857190 |
| CUSIP Number | n/a |
| ISIN Number | BE0974358906 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove NYXH